| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0221cfbb710aca0e7f791b87705949d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2427716fc69ab2e2d3493d8d6385c6aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b22263221cba5fcde82f61dbe007f286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b818cb56b5588f63bb26b10609e8a7e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P35-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-75 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P35-00 |
| filingDate |
1997-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2a0767d6dc8428fde9d4fb000791d1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_576cab8adad8a4e49e9d11746ebf5df7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4b9dacdf0ca19b16872b02f4960d285 |
| publicationDate |
1998-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9802567-A2 |
| titleOfInvention |
PROCESS FOR THE PREPARATION OF CEPHALOSPORINS USING $i(ACREMONIUM CHRYSOGENUM) |
| abstract |
The present invention describes a process wherein Acremonium is used as a suitable and convenient organism for the production of N-acylated cephalosporin derivatives. In the process of the invention, a recombinant, acyltransferase-expressing Acremonium strain is cultured in the presence of a suitable acyl side chain precursor. Optionally, the acyltransferase-expressing Acremonium strain further does not express hydroxylase and/or acetyltransferase activity. The N-acylated cephalosporin derivative is recovered without contaminating α-aminoadipyl cephalosporin compounds. The thus recovered compound subsequently may be deacylated via chemical or enzymatical means. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012032040-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021054545-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0078989-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115175992-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2165276-A1 |
| priorityDate |
1996-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |